|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
11432318 |
| 003 |
ICU |
| 005 |
20180109183010.3 |
| 008 |
160802s2017 nyua b 001 0 eng c |
| 010 |
|
|
|a 2016035246
|
| 040 |
|
|
|a DNLM/DLC
|b eng
|e rda
|c DLC
|d BTCTA
|d YDXCP
|d BDX
|d NLM
|d TMC
|d OCLCF
|d OCLCQ
|d OCLCO
|d OCLCA
|d STJ
|d YDX
|d OCLCO
|d IAT
|d VET
|d OCLCO
|d THHCU
|d OHS
|d UAB
|d OCLCQ
|d THHCU
|d IAA
|d OCLCA
|
| 019 |
|
|
|a 945359004
|a 955388314
|
| 020 |
|
|
|a 9781259587481
|q hardcover
|
| 020 |
|
|
|a 1259587487
|q hardcover
|
| 035 |
|
|
|a (OCoLC)955093124
|z (OCoLC)945359004
|z (OCoLC)955388314
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a RM263
|b .P56 2017
|
| 060 |
1 |
0 |
|a WB 330
|b P5357 2017
|
| 082 |
0 |
0 |
|a 615.5/8
|2 23
|
| 130 |
0 |
|
|a Pharmacotherapy (New York)
|
| 245 |
1 |
0 |
|a Pharmacotherapy :
|b a pathophysiologic approach /
|c editors, Joseph T. DiPiro, Robert L. Talbert, Gary C. Yee, Gary R. Matzke, Barbara G. Wells, L. Michael Posey ; associate editors, Vicki L. Ellingrod, Stuart T. Haines, Thomas D. Nolin.
|
| 250 |
|
|
|a Tenth edition.
|
| 264 |
|
1 |
|a New York :
|b McGraw-Hill Education,
|c [2017]
|
| 300 |
|
|
|a xxxiii, 2474 pages ;
|c 29 cm
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Section 1: Foundation Issues -- Chapter e1: Health Literacy and Medication Use -- Chapter e2: Cultural Competency -- Chapter e3: Medication Safety Principles and Practices -- Chapter e4: Clinical Pharmacokinetics and Pharmacodynamics -- Chapter e5: Pharmacogenetics -- Chapter e6: Pediatrics -- Chapter e7: Geriatrics -- Chapter e8: Palliative Care -- Chapter e9: Clinical Toxicology -- Chapter e10: Clinical Management of Potential Bioterrorism-related Conditions -- Section 2: Cardiovascular Disorders -- Chapter e11: Cardiovascular Testing -- Chapter 12: Cardiac Arrest -- Chapter 13: Hypertension -- Chapter 14: Chronic Heart Failure -- Chapter 15: Acute Decompensated Heart Failure -- Chapter 16: Stable Ischemic Heart Disease -- Chapter 17: Acute Coronary Syndromes -- Chapter 18: The Arrhythmias -- Chapter 19: Venous Thromboembolism -- Chapter 20: Stroke -- Chapter 21: Dyslipidemia -- Chapter e22: Peripheral Arterial Disease -- Chapter 23: Use of Vasopressors and Inotropes in the Pharmacotherapy of Shock -- Chapter 24: Hypovolemic Shock -- Chapter e25: Introduction to Pulmonary Function Testing -- Section 3: Respiratory Disorders -- Chapter 26: Asthma -- Chapter 27: Chronic Obstructive Pulmonary Disease -- Chapter 28: Pulmonary Arterial Hypertension -- Chapter 29: Cystic Fibrosis -- Chapter e30: Drug-Induced Pulmonary Diseases -- Section 4: Gastrointestinal Disorders -- Chapter e31: Evaluation of the Gastrointestinal Tract -- Chapter 32: Gastroesophageal Reflux Disease -- Chapter 33: Peptic Ulcer Disease and Related Disorders -- Chapter 34: Inflammatory Bowel Disease -- Chapter 35: Nausea and Vomiting -- Chapter 36: Diarrhea, Constipation, and Irritable Bowel Syndrome -- Chapter 37: Portal Hypertension and Cirrhosis -- Chapter e38: Drug-Induced Liver Disease -- Chapter 39: Pancreatitis -- Chapter 40: Viral Hepatitis -- Chapter 41: Celiac Disease -- Section 5: Renal Disorders -- Chapter e42: Evaluation of Kidney Function -- Chapter 43: Acute Kidney Injury -- Chapter 44: Chronic Kidney Disease -- Chapter 45: Hemodialysis and Peritoneal Dialysis -- Chapter 46: Drug-Induced Kidney Disease -- Chapter 47: Glomerulonephritis -- Chapter 48: Drug Therapy Individualization for Patients with Chronic Kidney Disease -- Chapter 49: Disorders of Sodium and Water Homeostasis -- Chapter 50: Disorders of Calcium and Phosphorus Homeostasis -- Chapter 51: Disorders of Potassium and Magnesium Homeostasis -- Chapter 52: Acid-Base Disorders -- Section 6: Neurologic Disorders -- Chapter e53: Evaluation of Neurologic Illness -- Chapter 54: Alzheimer Disease -- Chapter 55: Multiple Sclerosis -- Chapter 56: Epilepsy -- Chapter 57: Status Epilepticus -- Chapter 58: Acute Management of the Brain Injury Patient -- Chapter 59: Parkinson Disease -- Chapter 60: Pain Management -- Chapter 61: Headache Disorders -- Section 7: Psychiatric Disorders -- Chapter e62: Assessment of Psychiatric Disorders -- Chapter 63: Attention Deficit/Hyperactivity Disorder -- Chapter 64: Eating Disorders -- Chapter 65: Substance-Related Disorders I: Overview and Depressants, Stimulants, and Hallucinogens -- Chapter 66: Substance-Related Disorders II: Alcohol, Nicotine, and Caffeine -- Chapter 67: Schizophrenia -- Chapter 68: Major Depressive Disorder -- Chapter 69: Bipolar Disorder -- Chapter 70: Anxiety Disorders: Generalized Anxiety, Panic, and Social Anxiety Disorders.
|
| 505 |
0 |
|
|a Chapter 71: Posttraumatic Stress Disorder and Obsessive-Compulsive Disorder -- Chapter 72: Sleep-Wake Disorders -- Chapter 73: Disorders Associated with Intellectual Disabilities -- Section 8: Endocrinologic Disorders -- Chapter 74: Diabetes Mellitus -- Chapter 75: Thyroid Disorders -- Chapter 76: Adrenal Gland Disorders -- Chapter e77: Pituitary Gland Disorders -- Section 9: Gynecologic and Obstetric Disorders -- Chapter 78: Pregnancy and Lactation: Therapeutic Considerations -- Chapter 79: Contraception -- Chapter 80: Menstruation-Related Disorders -- Chapter 81: Endometriosis -- Chapter 82: Hormone Therapy in Women -- Section 10: Urologic Disorders -- Chapter 83: Erectile Dysfunction -- Chapter 84: Benign Prostatic Hyperplasia -- Chapter 85: Urinary Incontinence -- Section 11: Immunologic Disorders -- Chapter e86: Function and Evaluation of the Immune System -- Chapter 87: Systemic Lupus Erythematosus -- Chapter e88: Drug Allergy -- Chapter 89: Solid-Organ Transplantation -- Section 12: Rheumatologic Disorders -- Chapter 90: Osteoarthritis -- Chapter 91: Rheumatoid Arthritis -- Chapter 92: Osteoporosis and Osteomalacia -- Chapter 93: Gout and Hyperuricemia -- Section 13: Ophthalmic and Otolaryngological Disorders -- Chapter 94: Glaucoma -- Chapter 95: Allergic Rhinitis -- Section 14: Dermatologic Disorders -- Chapter 96: Acne Vulgaris -- Chapter 97: Psoriasis -- Chapter 98: Atopic Dermatitis -- Chapter e99: Dermatologic Drug Reactions and Common Skin Conditions -- Section 15: Hematologic Disorders -- Chapter 100: Anemias -- Chapter 101: Coagulation Disorders -- Chapter 102: Sickle Cell Disease -- Chapter e103: Drug-Induced Hematologic Disorders -- Section 16: Infectious Diseases -- Chapter e104: Laboratory Tests to Direct Antimicrobial Pharmacotherapy -- Chapter 105: Antimicrobial Regimen Selection -- Chapter 106: Central Nervous System Infections -- Chapter 107: Lower Respiratory Tract Infections -- Chapter 108: Upper Respiratory Tract Infections -- Chapter 109: Influenza -- Chapter 110: Skin and Soft-Tissue Infections -- Chapter 111: Infective Endocarditis -- Chapter 112: Tuberculosis -- Chapter 113: Gastrointestinal Infections and Enterotoxigenic Poisonings -- Chapter 114: Intra-Abdominal Infections -- Chapter 116: Urinary Tract Infections and Prostatitis -- Chapter e115: Parasitic Diseases -- Chapter 117: Sexually Transmitted Diseases -- Chapter 118: Bone and Joint Infections -- Chapter 119: Sepsis and Septic Shock -- Chapter 120: Superficial Fungal Infections -- Chapter 121: Invasive Fungal Infections -- Chapter 122: Infections in Immunocompromised Patients -- Chapter 123: Antimicrobial Prophylaxis in Surgery -- Chapter e124: Travel Health -- Chapter 125: Vaccines and Immunoglobulins -- Chapter 126: Human Immunodeficiency Virus Infection -- Section 17: Oncologic Disorders -- Chapter 127: Cancer Treatment and Chemotherapy -- Chapter 128: Breast Cancer -- Chapter 129: Lung Cancer -- Chapter 130: Colorectal Cancer -- Chapter 131: Prostate Cancer -- Chapter 132: Lymphomas -- Chapter 133: Ovarian Cancer -- Chapter 134: Acute Leukemias -- Chapter 135: Chronic Leukemias -- Chapter 136: Multiple Myeloma -- Chapter e137: Myelodysplastic Syndromes -- Chapter e138: Renal Cell Carcinoma -- Chapter 139: Melanoma -- Chapter 140: Hematopoietic Stem Cell Transplantation -- Section 18: Nutritional Disorders -- Chapter 141: Assessment of Nutrition Status and Nutrition Requirements -- Chapter 142: Parenteral Nutrition -- Chapter 143: Enteral Nutrition -- Chapter 144: Obesity.
|
| 650 |
|
0 |
|a Chemotherapy.
|0 http://id.loc.gov/authorities/subjects/sh85023041
|
| 650 |
1 |
2 |
|a Drug Therapy.
|
| 650 |
|
7 |
|a Chemotherapy.
|2 fast
|0 (OCoLC)fst00853595
|
| 700 |
1 |
|
|a DiPiro, Joseph T.,
|e editor.
|0 http://id.loc.gov/authorities/names/n88044759
|1 http://viaf.org/viaf/74091007
|
| 903 |
|
|
|a HeVa
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i bb8aa5e1-10d0-5ac1-a003-10b5e72af63d
|s cfc75b64-5cd9-567d-a432-f2359a4a4281
|
| 928 |
|
|
|t Library of Congress classification
|a RM263 .P56 2017
|l JCL
|c JCL-Sci
|i 10735414
|
| 927 |
|
|
|t Library of Congress classification
|a RM263 .P56 2017
|l JCL
|c JCL-Sci
|e BILL
|e CRERAR
|b 114313327
|i 9915250
|
